FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200433953> ?p ?o ?g. }

• W4200433953 endingPage "232" @default.
• W4200433953 startingPage "225" @default.
• W4200433953 abstract "To describe the medical and laboratory profile of the patients who have been diagnosed with chronic urticaria in the outpatient clinic of a tertiary care hospital of the social security system in Costa Rica.All patients over 13 years of age who had been diagnosed with chronic urticaria between January 1st, 2014, and December 31st, 2018 were included. Variables of medical and laboratory data were statistically analyzed, and the treatment of the patients between their first and last medical consultation was compared.This was about 160 patients who had been diagnosed with chronic urticaria; 129 of them were women, 45.7 % between the ages of 30-49 years; in 17.5 % of them (28 patients), inducible urticaria was associated; 54.8 % (46/84) had positive antithyroperoxidase antibodies; 16.9 % (27 patients) maintained a single dose of second-generation anti-H1 antihistamines in the last consultation; 16.3 % (26 patients) no longer required antihistamine treatment in the last consultation. Cyclosporine was used in 8.8 % (14 patients), and omalizumab was used in 2.5 % (four patients).Since this is a real-life study in a geographic region with limited publications on this pathology, we trust that the provided information will contribute to the scientific community in order to improve the quality of life of patients with chronic urticaria through a timely diagnosis and an effective and efficient treatment.Objetivo: Describir el perfil clínico y de laboratorio de los pacientes diagnosticados con urticaria crónica en la consulta externa de alergología en un hospital de tercer nivel de atención del sistema de seguridad social de Costa Rica. Métodos: Se incluyeron todos los pacientes mayores de 13 años diagnosticados con urticaria crónica entre el 1 de enero de 2014 y el 31 de diciembre de 2018. Se analizaron estadísticamente variables de datos clínicos y de laboratorio y se comparó el tratamiento de los pacientes entre la primera y última consulta. Resultados: Se trató de 160 pacientes con diagnóstico de urticaria crónica: 129 del sexo femenino, 45.7 % con edad entre 30 y 49 años, en 17.5 % (28 pacientes) se asoció urticaria inducible, 54.8 % (46/84) presentó anticuerpo antitiroperoxidasa positivo, 16.9 % (27 pacientes) se mantuvo en la última consulta con una dosis de antihistamínicos anti-H1 de segunda generación; 16.3 % (26 pacientes) ya no requería tratamiento antihistamínico en la última consulta. En 8.8 % de los casos (14 pacientes) se utilizó ciclosporina y en 2.5 % (cuatro pacientes), omalizumab. Conclusión: Al tratase de un estudio de vida real en una región geográfica con limitadas publicaciones sobre esta patología, confiamos que la información provista contribuya a la comunidad científica a mejorar la calidad de vida de los pacientes con urticaria crónica mediante un diagnóstico oportuno y un tratamiento eficaz y efectivo." @default.
• W4200433953 created "2021-12-31" @default.
• W4200433953 creator A5039755926 @default.
• W4200433953 creator A5043695382 @default.
• W4200433953 creator A5056251714 @default.
• W4200433953 creator A5088518131 @default.
• W4200433953 date "2021-12-03" @default.
• W4200433953 modified "2023-10-17" @default.
• W4200433953 title "Perfil clínico de los pacientes con urticaria crónica en un hospital de tercer nivel de atención del sistema de seguridad social de Costa Rica" @default.
• W4200433953 cites W1984804599 @default.
• W4200433953 cites W2007817444 @default.
• W4200433953 cites W2083240871 @default.
• W4200433953 cites W2087022491 @default.
• W4200433953 cites W2089383541 @default.
• W4200433953 cites W2093073735 @default.
• W4200433953 cites W2107412791 @default.
• W4200433953 cites W2109951782 @default.
• W4200433953 cites W2118314444 @default.
• W4200433953 cites W2129710299 @default.
• W4200433953 cites W2157377996 @default.
• W4200433953 cites W2165948492 @default.
• W4200433953 cites W2193048333 @default.
• W4200433953 cites W2328847226 @default.
• W4200433953 cites W2404489874 @default.
• W4200433953 cites W2518536270 @default.
• W4200433953 cites W2531076599 @default.
• W4200433953 cites W2589726146 @default.
• W4200433953 cites W2605712080 @default.
• W4200433953 cites W2617373847 @default.
• W4200433953 cites W2620638442 @default.
• W4200433953 cites W2755921806 @default.
• W4200433953 cites W2792948845 @default.
• W4200433953 cites W2797088994 @default.
• W4200433953 cites W2808588505 @default.
• W4200433953 cites W2810953097 @default.
• W4200433953 cites W2898883591 @default.
• W4200433953 cites W2899229070 @default.
• W4200433953 cites W2915952319 @default.
• W4200433953 cites W2947879370 @default.
• W4200433953 cites W2951361459 @default.
• W4200433953 cites W2953175323 @default.
• W4200433953 cites W2959650581 @default.
• W4200433953 cites W2970721464 @default.
• W4200433953 cites W4230208791 @default.
• W4200433953 cites W4246564728 @default.
• W4200433953 doi "https://doi.org/10.29262/ram.v68i4.881" @default.
• W4200433953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34904558" @default.
• W4200433953 hasPublicationYear "2021" @default.
• W4200433953 type Work @default.
• W4200433953 citedByCount "0" @default.
• W4200433953 crossrefType "journal-article" @default.
• W4200433953 hasAuthorship W4200433953A5039755926 @default.
• W4200433953 hasAuthorship W4200433953A5043695382 @default.
• W4200433953 hasAuthorship W4200433953A5056251714 @default.
• W4200433953 hasAuthorship W4200433953A5088518131 @default.
• W4200433953 hasBestOaLocation W42004339531 @default.
• W4200433953 hasConcept C126322002 @default.
• W4200433953 hasConcept C141105273 @default.
• W4200433953 hasConcept C159110408 @default.
• W4200433953 hasConcept C159654299 @default.
• W4200433953 hasConcept C187212893 @default.
• W4200433953 hasConcept C194828623 @default.
• W4200433953 hasConcept C203014093 @default.
• W4200433953 hasConcept C2776880894 @default.
• W4200433953 hasConcept C2778564945 @default.
• W4200433953 hasConcept C2779951463 @default.
• W4200433953 hasConcept C3017745231 @default.
• W4200433953 hasConcept C3018838755 @default.
• W4200433953 hasConcept C71924100 @default.
• W4200433953 hasConceptScore W4200433953C126322002 @default.
• W4200433953 hasConceptScore W4200433953C141105273 @default.
• W4200433953 hasConceptScore W4200433953C159110408 @default.
• W4200433953 hasConceptScore W4200433953C159654299 @default.
• W4200433953 hasConceptScore W4200433953C187212893 @default.
• W4200433953 hasConceptScore W4200433953C194828623 @default.
• W4200433953 hasConceptScore W4200433953C203014093 @default.
• W4200433953 hasConceptScore W4200433953C2776880894 @default.
• W4200433953 hasConceptScore W4200433953C2778564945 @default.
• W4200433953 hasConceptScore W4200433953C2779951463 @default.
• W4200433953 hasConceptScore W4200433953C3017745231 @default.
• W4200433953 hasConceptScore W4200433953C3018838755 @default.
• W4200433953 hasConceptScore W4200433953C71924100 @default.
• W4200433953 hasIssue "4" @default.
• W4200433953 hasLocation W42004339531 @default.
• W4200433953 hasLocation W42004339532 @default.
• W4200433953 hasLocation W42004339533 @default.
• W4200433953 hasOpenAccess W4200433953 @default.
• W4200433953 hasPrimaryLocation W42004339531 @default.
• W4200433953 hasRelatedWork W2429715903 @default.
• W4200433953 hasRelatedWork W2460943251 @default.
• W4200433953 hasRelatedWork W2899923123 @default.
• W4200433953 hasRelatedWork W2915939922 @default.
• W4200433953 hasRelatedWork W3021573807 @default.
• W4200433953 hasRelatedWork W3120529169 @default.
• W4200433953 hasRelatedWork W3160223294 @default.
• W4200433953 hasRelatedWork W4200433953 @default.
• W4200433953 hasRelatedWork W4224227857 @default.
• W4200433953 hasRelatedWork W4294859292 @default.

• next